Isoxsuprine
Active ingredient: Isoxsuprine Hydrochloride
In short: Based on a review of this drug by the National Academy of Sciences-National Research and/or other information, the FDA has classified the indications as follows: For the relief of symptoms associated with cerebrovascular insufficiency. In peripheral vascular disease of arteriosclerosis obliterans, t
What is Isoxsuprine used for?
Based on a review of this drug by the National Academy of Sciences-National Research and/or other information, the FDA has classified the indications as follows:
For the relief of symptoms associated with cerebrovascular insufficiency.
In peripheral vascular disease of arteriosclerosis obliterans, thromboangitis obliterans (Buerger's disease) and Raynaud's disease.
Final classification of the less-than-effective indications requires further investigation.
Isoxsuprine dosage
Oral: 10 to 20 mg, three or four times daily.
Warnings & precautions
Do not take this medicine if: There are no known contraindications to oral use when administered in recommended doses.
Isoxsuprine Hydrochloride, USP should not be given immediately postpartum or in the presence of arterial bleeding.
Safety and effectiveness in pediatric patients has not been established.
Isoxsuprine side effects
On rare occasion oral administration of the drug has been associated in time with the occurrence of hypotension, tachycardia, chest pain, nausea, vomiting, dizziness, abdominal distress, and severe rash. If rash appears, the drug should be discontinued.
Although available evidence suggests a temporal association of these reactions with Isoxsuprine Hydrochloride, a causal relationship can be neither confirmed nor refuted.
Beta Adrenergic receptor stimulants such as Isoxsuprine Hydrochloride have been used to inhibit pre-term labor.
Maternal and fetal tachycardia may occur under such use.
Hypocalcemia, hypoglycemia, hypotension and ileus have been reported to occur in infants whose mothers received Isoxsuprine Hydrochloride. Pulmonary edema has been reported in mothers treated with beta stimulants. Isoxsuprine Hydrochloride is neither approved nor recommended for use in the treatment of premature labor.
About this medicine
Each tablet taken orally contains Isoxsuprine Hydrochloride, USP with the following chemical structure:
p-Hydroxy-α[1-[(methyl-2-phenoxy-ethyl)amino]ethyl]benzyl alcohol hydrochloride.
Each tablet taken orally contains 20mg Isoxsuprine Hydrochloride.
Peripheral Vasodilator
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 908691b4-7950-4f3e-bbea-ea568fee7ac3. Read the full official label on DailyMed.